475 related articles for article (PubMed ID: 21570455)
1. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
Wu T; Zhou X; Deng Y; Jing Q; Li M; Yuan L
J Ethnopharmacol; 2011 Jun; 136(2):305-8. PubMed ID: 21570455
[TBL] [Abstract][Full Text] [Related]
2. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
McCue P; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory potential of selected Malaysian plants against key enzymes involved in hyperglycemia and hypertension.
Loh SP; Hadira O
Malays J Nutr; 2011 Apr; 17(1):77-86. PubMed ID: 22135867
[TBL] [Abstract][Full Text] [Related]
4. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
Ademiluyi AO; Oboh G
Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.
Kwon YI; Vattem DA; Shetty K
Asia Pac J Clin Nutr; 2006; 15(1):107-18. PubMed ID: 16500886
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water extractable phytochemicals from some tropical spices.
Adefegha SA; Oboh G
Pharm Biol; 2012 Jul; 50(7):857-65. PubMed ID: 22480175
[TBL] [Abstract][Full Text] [Related]
7. Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management.
Oboh G; Ademosun AO
Diabetes Metab Syndr; 2011; 5(3):148-52. PubMed ID: 22813568
[TBL] [Abstract][Full Text] [Related]
8. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.
Ademiluyi AO; Oboh G
J Basic Clin Physiol Pharmacol; 2012 Jan; 23(1):17-25. PubMed ID: 22865445
[TBL] [Abstract][Full Text] [Related]
9. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide.
Subramanian R; Asmawi MZ; Sadikun A
Acta Biochim Pol; 2008; 55(2):391-8. PubMed ID: 18511986
[TBL] [Abstract][Full Text] [Related]
10. Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models.
Pinto Mda S; Kwon YI; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
Bioresour Technol; 2009 Dec; 100(24):6599-609. PubMed ID: 19665890
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.
Sharifi-Rad M; Tayeboon GS; Sharifi-Rad J; Iriti M; Varoni EM; Razazi S
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):80-5. PubMed ID: 27262808
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
13. Effect of combination on the antioxidant and inhibitory properties of tropical pepper varieties against α-amylase and α-glucosidase activities in vitro.
Oboh G; Ademiluyi AO; Faloye YM
J Med Food; 2011 Oct; 14(10):1152-8. PubMed ID: 21663471
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
[TBL] [Abstract][Full Text] [Related]
15. Alpha-amylase inhibitory activity of two Anthocleista species and in vivo rat model anti-diabetic activities of Anthocleista djalonensis extracts and fractions.
Olubomehin OO; Abo KA; Ajaiyeoba EO
J Ethnopharmacol; 2013 Apr; 146(3):811-4. PubMed ID: 23422334
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiotensin-converting enzyme activity by a partially purified fraction of Gynura procumbens in spontaneously hypertensive rats.
Hoe SZ; Kamaruddin MY; Lam SK
Med Princ Pract; 2007; 16(3):203-8. PubMed ID: 17409755
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
Kwon YI; Apostolidis E; Shetty K
Bioresour Technol; 2008 May; 99(8):2981-8. PubMed ID: 17706416
[TBL] [Abstract][Full Text] [Related]
18. Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis.
Ibrahim MA; Koorbanally NA; Islam MS
Acta Pharm; 2014 Sep; 64(3):311-24. PubMed ID: 25296677
[TBL] [Abstract][Full Text] [Related]
19. Saponin rich fractions from Polygonatum odoratum (Mill.) Druce with more potential hypoglycemic effects.
Deng Y; He K; Ye X; Chen X; Huang J; Li X; Yuan L; Jin Y; Jin Q; Li P
J Ethnopharmacol; 2012 May; 141(1):228-33. PubMed ID: 22366676
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
Kwon YI; Jang HD; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
